Apr 20 |
Analysts' Revenue Estimates For Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Are Surging Higher
|
Apr 15 |
Certain Biotech Investors Get an Early Look at Results. Is That Fair?
|
Apr 10 |
Roblox, TAL Education And Other Big Stocks Moving Higher On Wednesday
|
Apr 9 |
Taysha draws bullish view at Piper Sandler on lead asset
|
Apr 9 |
Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
|
Mar 24 |
News Flash: Analysts Just Made A Notable Upgrade To Their Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Forecasts
|
Mar 21 |
Taysha Gene Therapies Full Year 2023 Earnings: Beats Expectations
|
Mar 20 |
Taysha: Initial Rett Syndrome Data Leads To Other 2024 Catalysts
|
Mar 20 |
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Q4 2023 Earnings Call Transcript
|
Mar 20 |
Taysha Gene Therapies Shares Jump On Initial Data From First Pediatric Patient With Rare Neurodevelopmental Disorder
|